The results showed that the overall expression level of mucin family and the patients with positive or high expression of MUC4 and MUC16 had a poor prognosis, indicating that mucin family can be used as a potential biomolecule to predict the prognosis of patients with pancreatic cancer. This evidence concerns the gene MUC16 and pancreatic neoplasm.